Indivior (INDV) Stock Forecast, Price Target & Predictions


OverviewRevenueFinancialsChartTranscripts

INDV Stock Forecast


Indivior (INDV) stock forecast, based on 3 Wall Street analysts, predicts a 12-month average price target of $17.50, with a high of $20.00 and a low of $15.00. This represents a 44.03% increase from the last price of $12.15.

$5 $8 $11 $14 $17 $20 High: $20 Avg: $17.5 Low: $15 Last Closed Price: $12.15

INDV Stock Rating


Indivior stock's rating consensus is Buy, based on 3 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 3 0 3 Strong Sell Sell Hold Buy Strong Buy

INDV Forecast vs Benchmarks


TypeNameUpside
StockIndivior44.03%
SectorHealthcare Stocks 25.20%
IndustrySpecialty & Generic Drug Manufacturers Stocks24.78%

Price Target Trends


1M3M12M
# Anlaysts--5
Avg Price Target--$23.60
Last Closing Price$12.15$12.15$12.15
Upside/Downside--94.24%
Ratings Trends

DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 2525---7
Dec, 2425---7
Nov, 2425---7
Oct, 2425---7
Sep, 2425---7
Latest Price Target by Analysts

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 11, 2024David AmsellemPiper Sandler$15.00$7.6197.11%23.46%
Sep 23, 2024Chase KnickerbockerCraig-Hallum$20.00$9.16118.34%64.61%
Sep 13, 2024David AmsellemPiper Sandler$22.00$9.62128.69%81.07%
Jul 10, 2024Chase KnickerbockerCraig-Hallum$24.00$10.19135.53%97.53%
Apr 03, 2024Chase KnickerbockerCraig-Hallum$37.00$21.4372.66%204.53%
Latest Upgrade/Downgrade by Analysts

DateCompanyPrevious RatingNew RatingRating Change
Oct 11, 2024Piper SandlerOverweightOverweighthold
Sep 23, 2024Craig-HallumBuyBuyhold
Sep 13, 2024Piper SandlerOverweightOverweighthold
Jul 23, 2024Piper SandlerOverweightinitialise
Jul 10, 2024Deutsche BankBuyBuyhold
Jul 10, 2024Craig-HallumBuyBuyhold
May 03, 2024Deutsche BankBuyinitialise
Apr 03, 2024Craig-HallumBuyinitialise

Financial Forecast


EPS Forecast

$-2 $-1 $0 $1 $2 $3 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.08$1.38$-0.37$0.01-----
Avg Forecast$0.16$0.74$1.09$1.39$1.65$1.53$1.93$2.18$2.24
High Forecast$0.16$0.72$1.02$1.33$1.49$1.04$1.85$2.09$2.14
Low Forecast$0.17$0.78$1.24$1.47$1.77$1.96$2.04$2.30$2.36
Surprise %-775.00%86.49%-133.94%-99.28%-----

Revenue Forecast

$600M $750M $900M $1B $1B $1B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$689.68M$777.48M$884.63M$1.12B-----
Avg Forecast$647.50M$757.87M$898.75M$1.08B$1.15B$1.07B$1.15B$1.24B$1.26B
High Forecast$630.73M$738.24M$854.51M$1.04B$1.11B$1.04B$1.12B$1.20B$1.22B
Low Forecast$670.33M$784.59M$995.95M$1.12B$1.16B$1.11B$1.20B$1.29B$1.31B
Surprise %6.51%2.59%-1.57%3.88%-----

Net Income Forecast

$-200M $-90M $20M $130M $240M $350M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-157.76M$205.00M$-52.04M$2.00M-----
Avg Forecast$22.85M$105.14M$154.10M$197.05M$234.56M$216.57M$274.08M$308.97M$316.92M
High Forecast$22.08M$101.61M$144.24M$189.01M$211.40M$147.33M$262.89M$296.35M$303.99M
Low Forecast$23.89M$109.96M$175.77M$207.85M$250.49M$278.45M$289.10M$325.90M$334.29M
Surprise %-790.53%94.97%-133.77%-98.99%-----

INDV Forecast FAQ


Is Indivior stock a buy?

Indivior stock has a consensus rating of Buy, based on 3 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Indivior is a favorable investment for most analysts.

What is Indivior's price target?

Indivior's price target, set by 3 Wall Street analysts, averages $17.5 over the next 12 months. The price target range spans from $15 at the low end to $20 at the high end, suggesting a potential 44.03% change from the previous close price of $12.15.

How does Indivior stock forecast compare to the average forecast of its sector, industry, and investment themes?

Indivior stock forecast shows a 44.03% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the specialty & generic drug manufacturers stocks industry (24.78%).

What is the breakdown of analyst ratings for Indivior over the past three months?

  • January 2025: 28.57% Strong Buy, 71.43% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 28.57% Strong Buy, 71.43% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 28.57% Strong Buy, 71.43% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Indivior’s EPS forecast?

Indivior's average annual EPS forecast for its fiscal year ending in December is 1.65 for 2024, a 16400.00% increase from the reported $0.01 in 2023. The prediction for 2025 is $1.53, $1.93 for 2026, $2.18 for 2027, and $2.24 for 2028.

What is Indivior’s revenue forecast?

Indivior's average annual revenue forecast for its fiscal year ending in December is $1.15B for 2024, a 2.62% increase from the reported $1.12B in 2023. The forecast for 2025 is $1.07B, $1.15B for 2026, $1.24B for 2027, and $1.26B for 2028.

What is Indivior’s net income forecast?

For its fiscal year ending in December, Indivior's average annual net income forecast is $234.56M for 2024, reflecting an 11628.21% increase from the reported $2M in 2023. The projection for 2025 is $216.57M, $274.08M for 2026, $308.97M for 2027, and $316.92M for 2028.